{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T08:27:43Z","timestamp":1769761663651,"version":"3.49.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T00:00:00Z","timestamp":1572825600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T00:00:00Z","timestamp":1572825600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"The Arthritis Society of Canada","award":["SOG-15-281"],"award-info":[{"award-number":["SOG-15-281"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n              <jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Fatigue is a common symptom of systemic autoimmune rheumatic disease (SARD). Patients with SARD have a protracted pre-clinical phase during which progressive immunologic derangements occur culminating in disease. In this study, we sought to determine when fatigue develops and whether its presence correlates with inflammatory factors or predicts disease progression.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Anti-nuclear antibody (ANA)-negative healthy controls (HCs) and ANA-positive participants with no criteria, at least one clinical criteria (undifferentiated connective tissue disease, UCTD), or meeting SARD classification criteria were recruited. Fatigue was assessed using a modified version of the FACIT-F questionnaire and the presence of fibromyalgia determined using a questionnaire based on the modified 2010 ACR criteria. Peripheral blood expression of five IFN-induced genes was quantified by NanoString and the levels of IL-1\u03b2, IL-6, or TNF-\u03b1 by ELISA.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Fatigue was as prevalent and severe in individuals lacking SARD criteria as it was in UCTD and SARD. Overall, ~\u20091\/3 of ANA<jats:sup>+<\/jats:sup> subjects met fibromyalgia criteria, with no differences between sub-groups. Although fatigue was more severe in these individuals, those lacking fibromyalgia remained significantly more fatigued than ANA<jats:sup>\u2212<\/jats:sup> HC. However, even in these subjects, fatigue correlated with the widespread pain index and symptom severity scores on the fibromyalgia questionnaire. Fatigue was not associated with elevated cytokine levels in any of the ANA<jats:sup>+<\/jats:sup> sub-groups and did not predict imminent disease progression.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Fatigue is common in ANA<jats:sup>+<\/jats:sup> individuals lacking sufficient criteria for a SARD diagnosis, correlates with fibromyalgia-related symptoms, and is not associated with inflammation or predictive of disease progression.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13075-019-2013-9","type":"journal-article","created":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T12:03:24Z","timestamp":1572869004000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Fatigue severity in anti-nuclear antibody-positive individuals does not correlate with pro-inflammatory cytokine levels or predict imminent progression to symptomatic disease"],"prefix":"10.1186","volume":"21","author":[{"given":"Waleed","family":"Hafiz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rawad","family":"Nori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariana","family":"Bregasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Babak","family":"Noamani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennisse","family":"Bonilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larissa","family":"Lisnevskaia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Earl","family":"Silverman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur A. M.","family":"Bookman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sindhu R.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina","family":"Landolt-Marticorena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5961-9228","authenticated-orcid":false,"given":"Joan","family":"Wither","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,11,4]]},"reference":[{"issue":"5","key":"2013_CR1","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1136\/ard.57.5.291","volume":"57","author":"PJ Barendregt","year":"1998","unstructured":"Barendregt PJ, Visser MR, Smets EM, Tulen JH, van den Meiracker AH, Boomsma F, Markusse HM. Fatigue in primary Sjogren\u2019s syndrome. Ann Rheum Dis. 1998;57(5):291\u20135.","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"2013_CR2","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1093\/rheumatology\/39.11.1249","volume":"39","author":"CM Tench","year":"2000","unstructured":"Tench CM, McCurdie I, White PD, D'Cruz DP. The prevalence and associations of fatigue in systemic lupus erythematosus. Rheumatology (Oxford). 2000;39(11):1249\u201354.","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"2013_CR3","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1002\/art.22910","volume":"57","author":"BD Thombs","year":"2007","unstructured":"Thombs BD, Taillefer SS, Hudson M, Baron M. Depression in patients with systemic sclerosis: a systematic review of the evidence. Arthritis Rheum. 2007;57(6):1089\u201397.","journal-title":"Arthritis Rheum"},{"issue":"12","key":"2013_CR4","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1002\/art.24311","volume":"59","author":"B Segal","year":"2008","unstructured":"Segal B, Thomas W, Rogers T, Leon JM, Hughes P, Patel D, Patel K, Novitzke J, Rohrer M, Gopalakrishnan R, et al. Prevalence, severity, and predictors of fatigue in subjects with primary Sjogren\u2019s syndrome. Arthritis Rheum. 2008;59(12):1780\u20137.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"2013_CR5","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1093\/rheumatology\/keq310","volume":"50","author":"M Bassel","year":"2011","unstructured":"Bassel M, Hudson M, Taillefer SS, Schieir O, Baron M, Thombs BD. Frequency and impact of symptoms experienced by patients with systemic sclerosis: results from a Canadian National Survey. Rheumatology (Oxford). 2011;50(4):762\u20137.","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"2013_CR6","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1136\/ard.58.6.379","volume":"58","author":"IN Bruce","year":"1999","unstructured":"Bruce IN, Mak VC, Hallett DC, Gladman DD, Urowitz MB. Factors associated with fatigue in patients with systemic lupus erythematosus. Ann Rheum Dis. 1999;58(6):379\u201381.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"2013_CR7","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.berh.2013.07.009","volume":"27","author":"A Schmeding","year":"2013","unstructured":"Schmeding A, Schneider M. Fatigue, health-related quality of life and other patient-reported outcomes in systemic lupus erythematosus. Best Pract Res Clin Rheumatol. 2013;27(3):363\u201375.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2013_CR8","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1477-7525-7-46","volume":"7","author":"B Segal","year":"2009","unstructured":"Segal B, Bowman SJ, Fox PC, Vivino FB, Murukutla N, Brodscholl J, Ogale S, McLean L. Primary Sjogren\u2019s syndrome: health experiences and predictors of health quality among patients in the United States. Health Qual Life Outcomes. 2009;7:46.","journal-title":"Health Qual Life Outcomes"},{"issue":"8","key":"2013_CR9","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1007\/s10067-012-1997-1","volume":"31","author":"G Strickland","year":"2012","unstructured":"Strickland G, Pauling J, Cavill C, McHugh N. Predictors of health-related quality of life and fatigue in systemic sclerosis: evaluation of the EuroQol-5D and FACIT-F assessment tools. Clin Rheumatol. 2012;31(8):1215\u201322.","journal-title":"Clin Rheumatol"},{"issue":"9","key":"2013_CR10","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1002\/art.24649","volume":"61","author":"PI Burgos","year":"2009","unstructured":"Burgos PI, Alarcon GS, McGwin G Jr, Crews KQ, Reveille JD, Vila LM. Disease activity and damage are not associated with increased levels of fatigue in systemic lupus erythematosus patients from a multiethnic cohort: LXVII. Arthritis Rheum. 2009;61(9):1179\u201386.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"2013_CR11","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1002\/art.27221","volume":"62","author":"GG Illei","year":"2010","unstructured":"Illei GG, Shirota Y, Yarboro CH, Daruwalla J, Tackey E, Takada K, Fleisher T, Balow JE, Lipsky PE. Tocilizumab in systemic lupus erythematosus: data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study. Arthritis Rheum. 2010;62(2):542\u201352.","journal-title":"Arthritis Rheum"},{"issue":"9","key":"2013_CR12","first-page":"1699","volume":"32","author":"RL Jump","year":"2005","unstructured":"Jump RL, Robinson ME, Armstrong AE, Barnes EV, Kilbourn KM, Richards HB. Fatigue in systemic lupus erythematosus: contributions of disease activity, pain, depression, and perceived social support. J Rheumatol. 2005;32(9):1699\u2013705.","journal-title":"J Rheumatol"},{"issue":"6","key":"2013_CR13","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1002\/art.1780380617","volume":"38","author":"PS McKinley","year":"1995","unstructured":"McKinley PS, Ouellette SC, Winkel GH. The contributions of disease activity, sleep patterns, and depression to fatigue in systemic lupus erythematosus. A proposed model. Arthritis Rheum. 1995;38(6):826\u201334.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"2013_CR14","first-page":"482","volume":"29","author":"R Omdal","year":"2002","unstructured":"Omdal R, Mellgren SI, Koldingsnes W, Jacobsen EA, Husby G. Fatigue in patients with systemic lupus erythematosus: lack of associations to serum cytokines, antiphospholipid antibodies, or other disease characteristics. J Rheumatol. 2002;29(3):482\u20136.","journal-title":"J Rheumatol"},{"issue":"9","key":"2013_CR15","first-page":"1999","volume":"28","author":"WG Tayer","year":"2001","unstructured":"Tayer WG, Nicassio PM, Weisman MH, Schuman C, Daly J. Disease status predicts fatigue in systemic lupus erythematosus. J Rheumatol. 2001;28(9):1999\u20132007.","journal-title":"J Rheumatol"},{"issue":"5","key":"2013_CR16","first-page":"892","volume":"25","author":"B Wang","year":"1998","unstructured":"Wang B, Gladman DD, Urowitz MB. Fatigue in lupus is not correlated with disease activity. J Rheumatol. 1998;25(5):892\u20135.","journal-title":"J Rheumatol"},{"issue":"7","key":"2013_CR17","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1093\/rheumatology\/32.7.633","volume":"32","author":"AJ Wysenbeek","year":"1993","unstructured":"Wysenbeek AJ, Leibovici L, Weinberger A, Guedj D. Fatigue in systemic lupus erythematosus. Prevalence and relation to disease expression. Br J Rheumatol. 1993;32(7):633\u20135.","journal-title":"Br J Rheumatol"},{"issue":"11","key":"2013_CR18","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1136\/ard.2007.083865","volume":"67","author":"S Dass","year":"2008","unstructured":"Dass S, Bowman SJ, Vital EM, Ikeda K, Pease CT, Hamburger J, Richards A, Rauz S, Emery P. Reduction of fatigue in Sjogren syndrome with rituximab: results of a randomised, double-blind, placebo-controlled pilot study. Ann Rheum Dis. 2008;67(11):1541\u20134.","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"2013_CR19","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1136\/ard.2003.011825","volume":"63","author":"A Hartkamp","year":"2004","unstructured":"Hartkamp A, Geenen R, Bijl M, Kruize AA, Godaert GL, Derksen RH. Serum cytokine levels related to multiple dimensions of fatigue in patients with primary Sjogren\u2019s syndrome. Ann Rheum Dis. 2004;63(10):1335\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"2013_CR20","doi-asserted-by":"publisher","first-page":"e000282","DOI":"10.1136\/rmdopen-2016-000282","volume":"2","author":"N Howard Tripp","year":"2016","unstructured":"Howard Tripp N, Tarn J, Natasari A, Gillespie C, Mitchell S, Hackett KL, Bowman SJ, Price E, Pease CT, Emery P, et al. Fatigue in primary Sjogren\u2019s syndrome is associated with lower levels of proinflammatory cytokines. RMD Open. 2016;2(2):e000282.","journal-title":"RMD Open"},{"issue":"4","key":"2013_CR21","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1002\/art.27314","volume":"62","author":"JM Meijer","year":"2010","unstructured":"Meijer JM, Meiners PM, Vissink A, Spijkervet FK, Abdulahad W, Kamminga N, Brouwer E, Kallenberg CG, Bootsma H. Effectiveness of rituximab treatment in primary Sjogren\u2019s syndrome: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2010;62(4):960\u20138.","journal-title":"Arthritis Rheum"},{"issue":"16","key":"2013_CR22","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1056\/NEJMoa021933","volume":"349","author":"MR Arbuckle","year":"2003","unstructured":"Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA, Harley JB. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med. 2003;349(16):1526\u201333.","journal-title":"N Engl J Med"},{"issue":"9","key":"2013_CR23","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1002\/art.39214","volume":"67","author":"E Theander","year":"2015","unstructured":"Theander E, Jonsson R, Sjostrom B, Brokstad K, Olsson P, Henriksson G. Prediction of Sjogren\u2019s syndrome years before diagnosis and identification of patients with early onset and severe disease course by autoantibody profiling. Arthritis Rheumatol. 2015;67(9):2427\u201336.","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"2013_CR24","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13075-017-1243-y","volume":"19","author":"J Wither","year":"2017","unstructured":"Wither J, Johnson SR, Liu T, Noamani B, Bonilla D, Lisnevskaia L, Silverman E, Bookman A, Landolt-Marticorena C. Presence of an interferon signature in individuals who are anti-nuclear antibody positive lacking a systemic autoimmune rheumatic disease diagnosis. Arthritis Res Ther. 2017;19(1):41.","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"2013_CR25","first-page":"313","volume":"21","author":"E Bodolay","year":"2003","unstructured":"Bodolay E, Csiki Z, Szekanecz Z, Ben T, Kiss E, Zeher M, Szucs G, Danko K, Szegedi G. Five-year follow-up of 665 Hungarian patients with undifferentiated connective tissue disease (UCTD). Clin Exp Rheumatol. 2003;21(3):313\u201320.","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"2013_CR26","first-page":"403","volume":"19","author":"I Cavazzana","year":"2001","unstructured":"Cavazzana I, Franceschini F, Belfiore N, Quinzanini M, Caporali R, Calzavara-Pinton P, Bettoni L, Brucato A, Cattaneo R, Montecucco C. Undifferentiated connective tissue disease with antibodies to Ro\/SSa: clinical features and follow-up of 148 patients. Clin Exp Rheumatol. 2001;19(4):403\u20139.","journal-title":"Clin Exp Rheumatol"},{"issue":"3 Suppl 33","key":"2013_CR27","first-page":"S14","volume":"22","author":"M Mosca","year":"2004","unstructured":"Mosca M, Baldini C, Bombardieri S. Undifferentiated connective tissue diseases in 2004. Clin Exp Rheumatol. 2004;22(3 Suppl 33):S14\u20138.","journal-title":"Clin Exp Rheumatol"},{"key":"2013_CR28","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jaut.2016.06.001","volume":"74","author":"R Lu","year":"2016","unstructured":"Lu R, Munroe ME, Guthridge JM, Bean KM, Fife DA, Chen H, Slight-Webb SR, Keith MP, Harley JB, James JA. Dysregulation of innate and adaptive serum mediators precedes systemic lupus erythematosus classification and improves prognostic accuracy of autoantibodies. J Autoimmun. 2016;74:182\u201393.","journal-title":"J Autoimmun"},{"issue":"11","key":"2013_CR29","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1136\/annrheumdis-2015-208140","volume":"75","author":"ME Munroe","year":"2016","unstructured":"Munroe ME, Lu R, Zhao YD, Fife DA, Robertson JM, Guthridge JM, Niewold TB, Tsokos GC, Keith MP, Harley JB, et al. Altered type II interferon precedes autoantibody accrual and elevated type I interferon activity prior to systemic lupus erythematosus classification. Ann Rheum Dis. 2016;75(11):2014\u201321.","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"2013_CR30","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1002\/art.40243","volume":"69","author":"M Cossu","year":"2017","unstructured":"Cossu M, van Bon L, Preti C, Rossato M, Beretta L, Radstake T. Earliest phase of systemic sclerosis typified by increased levels of inflammatory proteins in the serum. Arthritis Rheumatol. 2017;69(12):2359\u201369.","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"2013_CR31","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725.","journal-title":"Arthritis Rheum"},{"issue":"11","key":"2013_CR32","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","volume":"72","author":"F van den Hoogen","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, Matucci-Cerinic M, Naden RP, Medsger TA Jr, Carreira PE, et al. 2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative. Ann Rheum Dis. 2013;72(11):1747\u201355.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"2013_CR33","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1136\/ard.61.6.554","volume":"61","author":"C Vitali","year":"2002","unstructured":"Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, et al. Classification criteria for Sjogren\u2019s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61(6):554\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"2013_CR34","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0885-3924(96)00274-6","volume":"13","author":"SB Yellen","year":"1997","unstructured":"Yellen SB, Cella DF, Webster K, Blendowski C, Kaplan E. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manag. 1997;13(2):63\u201374.","journal-title":"J Pain Symptom Manag"},{"issue":"5","key":"2013_CR35","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1002\/acr.20140","volume":"62","author":"F Wolfe","year":"2010","unstructured":"Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, Russell AS, Russell IJ, Winfield JB, Yunus MB. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken). 2010;62(5):600\u201310.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"6","key":"2013_CR36","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.3899\/jrheum.100594","volume":"38","author":"F Wolfe","year":"2011","unstructured":"Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Hauser W, Katz RS, Mease P, Russell AS, Russell IJ, Winfield JB. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia. J Rheumatol. 2011;38(6):1113\u201322.","journal-title":"J Rheumatol"},{"issue":"5","key":"2013_CR37","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1023\/A:1008978114650","volume":"9","author":"AJ Patterson","year":"2000","unstructured":"Patterson AJ, Brown WJ, Powers JR, Roberts DC. Iron deficiency, general health and fatigue: results from the Australian Longitudinal Study on Women\u2019s Health. Qual Life Res. 2000;9(5):491\u20137.","journal-title":"Qual Life Res"},{"issue":"10","key":"2013_CR38","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1507\/endocrj.EJ16-0109","volume":"63","author":"JH An","year":"2016","unstructured":"An JH, Kim YJ, Kim KJ, Kim SH, Kim NH, Kim HY, Kim NH, Choi KM, Baik SH, Choi DS, et al. L-carnitine supplementation for the management of fatigue in patients with hypothyroidism on levothyroxine treatment: a randomized, double-blind, placebo-controlled trial. Endocr J. 2016;63(10):885\u201395.","journal-title":"Endocr J"},{"issue":"3","key":"2013_CR39","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/papt.12118","volume":"90","author":"J Daniels","year":"2017","unstructured":"Daniels J, Brigden A, Kacorova A. Anxiety and depression in chronic fatigue syndrome\/myalgic encephalomyelitis (CFS\/ME): examining the incidence of health anxiety in CFS\/ME. Psychol Psychother. 2017;90(3):502\u20139.","journal-title":"Psychol Psychother"},{"issue":"5","key":"2013_CR40","doi-asserted-by":"publisher","first-page":"403","DOI":"10.3109\/07357909709047578","volume":"15","author":"J Rinehart","year":"1997","unstructured":"Rinehart J, Hersh E, Issell B, Triozzi P, Buhles W, Neidhart J. Phase 1 trial of recombinant human interleukin-1 beta (rhIL-1 beta), carboplatin, and etoposide in patients with solid cancers: Southwest Oncology, Group Study 8940. Cancer Investig. 1997;15(5):403\u201310.","journal-title":"Cancer Investig"},{"key":"2013_CR41","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/j.1749-6632.2012.06634.x","volume":"1261","author":"N Rohleder","year":"2012","unstructured":"Rohleder N, Aringer M, Boentert M. Role of interleukin-6 in stress, sleep, and fatigue. Ann N Y Acad Sci. 2012;1261:88\u201396.","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"2013_CR42","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/art.21838","volume":"55","author":"LW Moreland","year":"2006","unstructured":"Moreland LW, Genovese MC, Sato R, Singh A. Effect of etanercept on fatigue in patients with recent or established rheumatoid arthritis. Arthritis Rheum. 2006;55(2):287\u201393.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"2013_CR43","first-page":"635","volume":"35","author":"EC Goligher","year":"2008","unstructured":"Goligher EC, Pouchot J, Brant R, Kherani RB, Avina-Zubieta JA, Lacaille D, Lehman AJ, Ensworth S, Kopec J, Esdaile JM, et al. Minimal clinically important difference for 7 measures of fatigue in patients with systemic lupus erythematosus. J Rheumatol. 2008;35(4):635\u201342.","journal-title":"J Rheumatol"},{"issue":"6","key":"2013_CR44","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1007\/s11926-006-0037-z","volume":"8","author":"R Staud","year":"2006","unstructured":"Staud R. Are patients with systemic lupus erythematosus at increased risk for fibromyalgia? Curr Rheumatol Rep. 2006;8(6):430\u20135.","journal-title":"Curr Rheumatol Rep"},{"issue":"12","key":"2013_CR45","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1093\/rheumatology\/32.12.1072","volume":"32","author":"B Gudbjornsson","year":"1993","unstructured":"Gudbjornsson B, Broman JE, Hetta J, Hallgren R. Sleep disturbances in patients with primary Sjogren\u2019s syndrome. Br J Rheumatol. 1993;32(12):1072\u20136.","journal-title":"Br J Rheumatol"},{"issue":"2","key":"2013_CR46","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s10067-015-3035-6","volume":"35","author":"CL Overman","year":"2016","unstructured":"Overman CL, Kool MB, Da Silva JA, Geenen R. The prevalence of severe fatigue in rheumatic diseases: an international study. Clin Rheumatol. 2016;35(2):409\u201315.","journal-title":"Clin Rheumatol"},{"issue":"6","key":"2013_CR47","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1111\/1756-185X.13320","volume":"21","author":"SJ Moon","year":"2018","unstructured":"Moon SJ, Kang KY, Kwok SK, Ju JH, Hong YS, Park SH, Jeon CH, Choi ST, Song JS, Min JK. Differences in quality of life determinants according to the presence of fibromyalgia in middle-aged female patients with systemic lupus erythematosus: a multicenter, cross-sectional, single-ethnicity cohort. Int J Rheum Dis. 2018;21(6):1173\u201384.","journal-title":"Int J Rheum Dis"},{"issue":"6 Suppl 74","key":"2013_CR48","first-page":"117","volume":"30","author":"C Iannuccelli","year":"2012","unstructured":"Iannuccelli C, Spinelli FR, Guzzo MP, Priori R, Conti F, Ceccarelli F, Pietropaolo M, Olivieri M, Minniti A, Alessandri C, et al. Fatigue and widespread pain in systemic lupus erythematosus and Sjogren\u2019s syndrome: symptoms of the inflammatory disease or associated fibromyalgia? Clin Exp Rheumatol. 2012;30(6 Suppl 74):117\u201321.","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"2013_CR49","first-page":"35","volume":"105","author":"S Perrot","year":"2017","unstructured":"Perrot S, Peixoto M, Dieude P, Hachulla E, Avouac J, Ottaviani S, Allanore Y. Patient phenotypes in fibromyalgia comorbid with systemic sclerosis or rheumatoid arthritis: influence of diagnostic and screening tests. Screening with the FiRST questionnaire, diagnosis with the ACR 1990 and revised ACR 2010 criteria. Clin Exp Rheumatol. 2017;105(3):35\u201342 35 Suppl.","journal-title":"Clin Exp Rheumatol"},{"issue":"2 Suppl 96","key":"2013_CR50","first-page":"S9","volume":"34","author":"BY Choi","year":"2016","unstructured":"Choi BY, Oh HJ, Lee YJ, Song YW. Prevalence and clinical impact of fibromyalgia in patients with primary Sjogren\u2019s syndrome. Clin Exp Rheumatol. 2016;34(2 Suppl 96):S9\u201313.","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"2013_CR51","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1186\/s13075-014-0470-8","volume":"16","author":"HG Schaible","year":"2014","unstructured":"Schaible HG. Nociceptive neurons detect cytokines in arthritis. Arthritis Res Ther. 2014;16(5):470.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"2013_CR52","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s13075-018-1752-3","volume":"20","author":"Y Baglaenko","year":"2018","unstructured":"Baglaenko Y, Chang NH, Johnson SR, Hafiz W, Manion K, Ferri D, Noamani B, Bonilla D, Rusta-Sellehy S, Lisnevskaia L, et al. The presence of anti-nuclear antibodies alone is associated with changes in B cell activation and T follicular helper cells similar to those in systemic autoimmune rheumatic disease. Arthritis Res Ther. 2018;20(1):264.","journal-title":"Arthritis Res Ther"},{"issue":"10","key":"2013_CR53","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1136\/annrheumdis-2018-213386","volume":"77","author":"MY Md Yusof","year":"2018","unstructured":"Md Yusof MY, Psarras A, El-Sherbiny YM, Hensor EMA, Dutton K, Ul-Hassan S, Zayat AS, Shalbaf M, Alase A, Wittmann M, et al. Prediction of autoimmune connective tissue disease in an at-risk cohort: prognostic value of a novel two-score system for interferon status. Ann Rheum Dis. 2018;77(10):1432\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"2013_CR54","doi-asserted-by":"publisher","first-page":"109","DOI":"10.5152\/eurjrheum.2015.0029","volume":"2","author":"SC Sandikci","year":"2015","unstructured":"Sandikci SC, Ozbalkan Z. Fatigue in rheumatic diseases. Eur J Rheumatol. 2015;2(3):109\u201313.","journal-title":"Eur J Rheumatol"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-019-2013-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13075-019-2013-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-019-2013-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T00:24:34Z","timestamp":1604363074000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-019-2013-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,4]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2013"],"URL":"https:\/\/doi.org\/10.1186\/s13075-019-2013-9","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,4]]},"assertion":[{"value":"3 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Research Ethics Boards of the University Health Network (12-5455-BE) and Mount Sinai Hospital, and all participants signed informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"223"}}